Adalimumab versus infliximab in treating post-operative recurrence of Crohn's disease: a national cohort study

by Carmen-Monica Preda, Larisa-Elena Fulger, Lucian Negreanu, Mircea Manuc, Irina Sandra, Mircea Diculescu